Physician Assistant Studies

Principal Faculty, Assistant Professor

 

Education & Training

• 2018 – PGY2 Solid Organ Transplant Residency, Mayo Clinic Florida, Jacksonville, FL
• 2017 – PGY1 Acute Care Pharmacy Residency, UC San Diego Health, San Diego, CA
• 2016 – Doctor of Pharmacy, Northeastern University, Boston, MA
• 2015 – Bachelor of Science in Pharmacy Studies, Northeastern University, Boston, MA

  Interests

• Chronic Disease Management
• Medication Therapy Management
• Medication Safety
• Transplantation
• Immunology
• Pharmacogenomics
• Interprofessional Education

Bio:

Dr. Zahid is a board-certified pharmacist with extensive clinical experience spanning pharmacotherapy, chronic disease management, medication therapy management, and transplantation/immunology.

 

She began her career as a lung transplant pharmacist at Montefiore Medical Center in Bronx, NY from 2018-2021, where in addition to providing comprehensive care to a complex patient population, she also held adjunct instructor academic appointments. She then practiced as a kidney/pancreas transplant pharmacist with the Miami Transplant Institute in Miami, FL from 2021-2022 in both the inpatient and outpatient settings before moving to Ann Arbor, MI. In Summer 2023, she and her family moved down to Toledo, OH. She joined KidneyLink in 2024 as a clinical pharmacist and provided personalized, value-based, patient-centered multidisciplinary care to high-risk CKD, ESRD, and kidney transplant patients across the kidney disease spectrum.

 

Dr. Zahid joined the UToledo PA Program in Fall 2026 and serves as Course Director and Principal Faculty for the Fundamentals of Pharmacology series. She is passionate about helping students bridge the gap between foundational pharmacology concepts and real-world clinical decision making – and preparing future healthcare providers to make safe, effective, and evidence-based treatment decisions.

 

Publications:

• Whitt JFrancois, Centeno A, Harrison T, Cabrera P, Zahid S, Chen L. Optimizing Multimodal Pain Control Post Laparoscopic Living Donor Nephrectomy. American Journal of Transplantation. 2022; 22 (S3).
• Nnani DU, Campbell A, Ajaimy M, Saeed O, Patel SR, Ahmed S, Graham JA, Jorde UP. Effect of Glecaprevir/Pibrentasvir on Weight-Adjusted Tacrolimus Trough/Dose Ratios in Heart and Kidney Transplant Recipients. Transplant Infectious Disease. 2021; 23: e13716.
• Alsunaid S, Ahmed S, Qama E, Caputo V, Stryker K, Covolai A, Mansour A. Temporal Relationship between Diffuse Alveolar Hemorrhage and Detection of DQ-DSAs in Lung Transplant Recipients. Transplantation. 2021; 160(4): A2491
• Caputo V, Stryker K, Ahmed S, Alsunaid S, Mansour A, Abbasi M, Forest S, Scheinin SA, Seethamraju H. Lung Herniation and Torsion Contributing to Persistent RV Dysfunction after Heart-Lung Transplant. Journal of Heart and Lung Transplantation. 2021; 40(4S): S312.
• Stryker K, Ahmed S, Caputo V, Alsunaid S, Mansour A, Abbasi M, Forest S, Seethamraju H, Scheinin SA. Successful Multi-Modal Treatment of Endobronchial Mucormycosis Infection of Native Lung after Lung Transplant. Journal of Heart and Lung Transplantation. 2021; 40(4S): S343.
• Skendelas JP, Phan D, Caputo V, Stryker K, Ahmed S, Joseph R, Philippsborn P, Thalappillil J, Scheinin SA, Seethamraju H. Novel CCR5 Antagonist for the Treatment of Mild-Moderate COVID-19 Infection after Lung Transplant. Journal of Heart and Lung Transplantation. 2021; 40(4S): S315.
• Ahmed S, Seethamraju H. CYP3A5 Polymorphisms and Conversion to Once-Daily, Extended-Release Tacrolimus in Lung Transplant. Journal of Heart and Lung Transplantation. 2020; 39(4): S320.
• Patel A, Ahmed S, Soto-Arenall M, Patel P, Yip D. Association of Time to Therapeutic Calcineurin Inhibitor Level to Biopsy Proven Acute Rejection after Heart Transplantation. Journal of Heart and Lung Transplantation. 2019; 38(4): S306.
• Ahmed S, Soto-Arenall M, Jackson D, Erasmus D. Efficacy of Bronchoscopically Administered Surfactant in the Setting of Primary Graft Dysfunction After Lung Transplantation. American Journal of Transplantation. 2017; 17(S3).
• Khan F, Ahmed S, Humber D, Pollema T, Birgersdotter-Green U, Pretorius GV. The Incidence of Bleeding Complications Associated with Pacemaker and ICD Lead Explantation without Reversal of Anticoagulation. EP Europace. 2017; 19(S3): iii4.